Humboldt Fund
New York City, New Yorkhumboldtfund.com
Overview
Humboldt Fund is a venture capital fund that supports innovative, early-stage companies by investing in the biotech revolution . The firm seeks to invest in biotech companies including molecular biology, biomaterials, genetics, mechanical engineering, artificial intelligence, and tissue engineering sectors . Humboldt Fund stands behind early-stage companies that synthesize engineering with physical and life sciences to create technologies that disrupt global conventions to solve critical issues of our time, while creating value and prosperity .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Spiral Therapeutics | Jan 2023 | VC Round | Co-investor |
| Deciduous Therapeutics | Dec 2022 | Series A | Co-investor |
| Endpoint Health | Jun 2022 | Series A | Co-investor |
| PhageLab | May 2022 | Series A | Co-investor |
| Ansa Biotechnologies | Apr 2022 | Series A | Co-investor |
Key People
Benjamin Quiroga
General Partner
Francisco Dopazo
General Partner
Sebastian Bernales
General Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
